Cargando…
GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
GFAPδ, the delta isoform of the glial fibrillary acidic protein, is mainly expressed in the subventricular zone of the brain, together with other neural stem cell markers like nestin. The authors of this paper were among the first that described in detail the expression of GFAPδ and its correlation...
Autores principales: | Radu, Roxana, Petrescu, George E. D., Gorgan, Radu M., Brehar, Felix M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971704/ https://www.ncbi.nlm.nih.gov/pubmed/35372061 http://dx.doi.org/10.3389/fonc.2022.859247 |
Ejemplares similares
-
Fighting Cancer Stem Cell Fate by Targeting LIS1 a WD40 Repeat Protein
por: Brehar, Felix M., et al.
Publicado: (2019) -
Preferential Association of Lissencephaly-1 Gene Expression with CD133+ Glioblastoma Cells
por: Brehar, Felix Mircea, et al.
Publicado: (2017) -
CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
por: Huang, Maotuan, et al.
Publicado: (2023) -
The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
por: Feng, Songshan, et al.
Publicado: (2022) -
GFAPδ/GFAPα ratio directs astrocytoma gene expression towards a more malignant profile
por: Stassen, Oscar M.J.A., et al.
Publicado: (2017)